Challenges for the maintaining the microbiological safety of the UK blood supply

The supply of blood, blood products and components in the UK, as elsewhere, is safe, although there is no cause for complacency. Use of blood, blood products and components is not without risk of morbidity and mortality. Transfusion -transmitted infections (TTIs) continue to occur and may severely affect the health and welfare of recipients. As indicated by recent and current inquiries, public interest in these TTIs is huge. The risk of TTI can be mitigated but not abolished. Measures to reduce risk include screening of donors, testing of donations and, where appropriate, treatment of donations. The introduction of newer screening tests might identify some infectious donations but come at a cost, which could exceed a justifiable limit. Thus, the recognition, detection, reporting and investigation of cases of possible TTIs need to be improved. Recipients of blood should understand that, although transfusion in the UK is safe, it is not free of risk and so should be provided with full information so that properly informed consent can be given.

Automated summary

The supply of blood, blood products and components in the UK, as elsewhere, is safe, but not without risk. Measures to reduce risk, such as screening of donors and testing of donations, should be implemented. Improvement in the recognition, detection, reporting and investigation of cases of possible transfusion-transmitted infections is necessary. Properly informed consent should be obtained from blood recipients as transfusion is not risk-free.